Stay updated on Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRecruitment status updated to 'No longer looking for participants'. A new Revision: v3.6.0 entry was added and the previous Revision: v3.5.5 entry was removed.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision label in the page footer updated from v3.5.4 to v3.5.5. This reflects a newer site revision.SummaryDifference0.0%

- Check40 days agoChange DetectedA new version entry (210) was added, updating the Study Status and Arms and Interventions sections and applying revision v3.5.4; this follows the prior revision v3.5.3.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page’s interface revision indicator was updated from v3.5.2 to v3.5.3, reflecting a minor website/version update rather than a change to the clinical trial information.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded a new 'Study Status' entry to the version history and updated the page revision from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check76 days agoChange DetectedNew history entries 204–207 (dated 2026-04-04 to 2026-04-09) appear; the log now includes a Study Status entry in the changes.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.